NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 2,040.00
-90.00 (-4.23%)
At close: Feb 20, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 52.1 billion as of February 20, 2026. Its market cap has increased by 58.73% in one year.
Market Cap
52.10B
Enterprise Value
62.38B
Revenue
9.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,040.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 52.10B, a decrease of -83.37%. That is a compound annual growth rate of -29.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 52.10B | 42.51% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shaperon | 87.82B |
| Parataxis Korea | 82.21B |
| HLB Pep | 74.35B |
| CHA Vaccine Research Institute | 72.40B |
| PanGen Biotech | 71.25B |
| Ark Solutions | 68.91B |
| SunBio,Inc. | 67.31B |
| EyeGene | 62.12B |